Alzheimer’s Sleep Loss Reversed by Targeting Overactive Brain Immune Cells

Researchers have identified overactive immune cells in the brain as a key factor in sleep loss associated with Alzheimer’s disease. By temporarily removing these cells in mice, scientists restored over two hours of sleep per day, highlighting a novel potential treatment avenue. This discovery offers new hope for addressing sleep disturbances in Alzheimer’s patients.

Originally published by gnews